CCR4 and neoplasm: In a previous study, we showed in a syngeneic in vivo model using PDA6606 cells in C57BL/6 mice that pharmacological or steric inhibition with blocking antibodies targeting CCR4 significantly increased the survival of tumor-bearing mice [38].